The Centers for Medicare & Medicaid Services this week awarded 14 states and the District of Columbia planning grants totaling $48.5 million to increase access to evidence-based treatment and recovery services for Medicaid patients with substance use disorders. Alabama, Connecticut, Delaware, the District of Columbia, Illinois, Indiana, Kentucky, Maine, Michigan, Nevada, New Mexico, Rhode Island, Virginia, Washington and West Virginia will use the grants to assess state needs, recruit and train providers, and improve reimbursement to expand treatment capacity. Section 1003 of the Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 authorized the planning grants for a demonstration project to increase Medicaid provider capacity to treat SUDs. CMS will select up to five of the states to receive an enhanced federal matching rate for SUD services for three years under the project.

Related News Articles

Perspective
Public
More than 48 million Americans — 16.8% of the 12-and-older population — have a substance use disorder (SUD), according to the 2025 National Survey on Drug Use…
Headline
HHS awards $1.5 billion in opioid response grants to states, tribal communities The Department of Health and Human Services announced yesterday that it…
Headline
The Senate Sept. 18 passed the AHA-supported SUPPORT Act (H.R. 2483) by a voice vote, advancing the bill to President Trump to sign into law. The bill…
Headline
A bipartisan House letter by Reps. Dan Crenshaw, R-Texas, Yvette D. Clarke, D-N.Y., Gus M. Bilirakis, R-Fla., and Diana DeGette, D-Colo., urged House…
Headline
The AHA detailed its key health care priorities for the remainder of the year in comments to House and Senate majority and minority leaders Sept. 15. The AHA…
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…